高级检索
当前位置: 首页 > 详情页

MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Clin Pharm, Guangzhou, Guangdong, Peoples R China [2] Guangzhou Univ Chinese Med, Postdoctoral Sci Res, Guangzhou, Guangdong, Peoples R China [3] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China [4] Guangzhou Univ Chinese Med, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China [5] Guangzhou Univ Chinese, Affiliated Hosp 2, Sect Immunol & Chinese Med, Guangzhou, Guangdong, Peoples R China
出处:
ISSN:

摘要:
The main pathological characteristics of chronic glomerulonephritis (CGN) are diffuse mesangial cells proliferation and inflammatory responses. Our previous studies have confirmed that miR-145-5p was abnormally elevated in CGN rats, but its mechanism remains unclear. Therefore, this study aimed to elucidate the mechanism of miR-145-5p in regulation of renal mesangial cells proliferation and inflammatory responses. In vivo study, the cationic bovine serum albumin (C-BSA)-induced CGN rat model was established, and the content of miR-145-5p in renal was examined by qRT-PCR, meanwhile, we also determined the renal function and inflammatory infiltrate. In vitro, the cell proliferation rate, cell cycle and inflammatory changes of rat mesangial cells (RMCs) were measured. Our results suggested that miR-145-5p extended the G0-G1 phase, shortened S phase, inhibited cell proliferation and suppressed inflammatory responses in RMCs. Moreover, miR-145-5p inhibited CXCL16 protein expression through binding the 3-UTR of CXCL16, suppressed AKT/GSK signaling pathway, and decreased expression of inflammation related mRNAs, such as IL-1, IL-2, IL-6, and TNF- mRNAs. Further, locking CXCL16 alleviated inflammatory reactions and down-regulated AKT/GSK pathway in RMCs. Above all, we concluded that miR-145-5p inhibited proliferation and inflammatory responses of RMCs through regulation of AKT/GSK pathway by targeting CXCL16.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 2 区 生理学 3 区 细胞生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 细胞生物学 3 区 生理学
JCR分区:
出版当年[2016]版:
Q1 PHYSIOLOGY Q2 CELL BIOLOGY
最新[2023]版:
Q1 PHYSIOLOGY Q2 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Clin Pharm, Guangzhou, Guangdong, Peoples R China [2] Guangzhou Univ Chinese Med, Postdoctoral Sci Res, Guangzhou, Guangdong, Peoples R China
通讯作者:
通讯机构: [*1]Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China [3] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号